2017-11-10T10:02:03-06:00 2016-12-31 410746749 CLIFTONLARSONALLEN LLP 901 N GLEBE ROAD SUITE 200 ARLINGTON VA 22203 990 2016-01-01 521224577 BIOTECHNOLOGY INNOVATION ORGANIZATION BIOT 2029629200 1201 MARYLAND AVENUE SW NO 900 WASHINGTON DC 20024 YVETTE WHITE-WIGGINS CFO AND SVP, FINANCE & ADMIN 2029629200 2017-11-10 1 DAVID TRIMNER CPA P00444822 5712279500 67.137.57.251 2017-11-10 08:44:50 ES P EB2200476D68FB6EEC1AFAD6F1D2D29456870623 D4C9CCF27C82EE891DBBD0A0F5B8A17B08786766 2016 2017-02-10 21:41:12Z JAMES C GREENWOOD 1201 MARYLAND AVENUE SW NO 900 WASHINGTON DC 20024 77004582 0 X WWW.BIO.ORG X 1993 DC SUPPORT THE BIOTECHNOLOGY INDUSTRY TO EXPAND THE BOUNDARIES OF SCIENCE TO BENEFIT MANKIND. 114 114 210 176 411568 -462 0 0 59447799 64830661 9300167 1712696 5776554 10372053 74524520 76915410 484833 596583 0 0 30323673 31655808 0 0 0 36991328 47122286 67799834 79374677 6724686 -2459267 73452800 73322307 33238643 33540196 40214157 39782111 X THE BIOTECHNOLOGY INNOVATION ORGANIZATION (BIO) REPRESENTS APPROXIMATELY 1,000 COMPANIES AND ORGANIZATIONS IN WASHINGTON DC, STATE CAPITALS, AND INTERNATIONAL FORA. BIO IS FOUNDED ON THE PRINCIPLE THAT POLICY MUST NURTURE INNOVATION IN THE LIFE SCIENCES TO OVERCOME CHALLENGES IN HEALTH CARE, AGRICULTURE, INDUSTRY, AND THE ENVIRONMENT. OUR MEMBERS REPRESENT COMPANIES OFFERING A SPECTRUM OF BIOTECHNOLOGY APPLICATIONS ACROSS MAJOR SECTORS OF THE ECONOMY. BIO MEMBERS ALSO INCLUDE UNIVERSITIES, NONPROFITS, PATIENT GROUPS, AND OTHER ORGANIZATIONS THAT PLAY AN IMPORTANT ROLE IN THE FUTURE OF THE LIFE SCIENCES. BIO'S ACTIVITIES ARE BROKEN DOWN INTO TWO PROGRAMS - ADVOCACY AND SERVICES. 0 0 ADVOCACY: BIOTECHNOLOGY INNOVATION ORGANIZATION (BIO)'S ADVOCACY EFFORTS REFLECT THE PRIORITIES IDENTIFIED BY THE BIO BOARD OF DIRECTORS AND THE FOUR SECTION GOVERNING BOARDS.THE BOARD OF DIRECTORS FOCUSES ON ISSUES OF IMPORTANCE TO ALL BIO MEMBERS, REGARDLESS OF THEIR SIZE OR TECHNOLOGY. THESE CROSS-CUTTING ADVOCACY ACCOMPLISHMENTS IN 2016 ARE LISTED BELOW: - SAFEGUARDED AND ADVANCED INTELLECTUAL PROPERTY PROTECTIONS, DOMESTICALLY AND INTERNATIONALLY.- FOSTERED A DIALOGUE ABOUT BIOETHICS AND PROACTIVELY ADVANCED THE SOCIALLY RESPONSIBLE USE OF BIOTECHNOLOGY.- PROMOTED INVESTMENT IN GOVERNMENT AND ACADEMIC RESEARCH.- PROMOTED COMPREHENSIVE REFORM OF THE U.S. TAX CODE TO SPUR INNOVATION AND INVESTMENT IN BIOTECHNOLOGY.- EXPANDED OUTREACH TO FOREIGN GOVERNMENTS AND INTERNATIONAL ENTITIES TO EDUCATE ON POLICY ISSUES OF IMPORTANCE TO THE BIOTECHNOLOGY INDUSTRY AND TO IMPROVE THE INVESTMENT AND REGULATORY CLIMATE FOR BIOTECH PRODUCTS.THE HEALTH SECTION 2016 ADVOCACY ACCOMPLISHMENTS: - ADVOCATED FOR THE PASSAGE OF THE 21ST CENTURY CURES ACT - SUCCESSFULLY FINISHED NEGOTIATIONS ON REAUTHORIZING THE PRESCRIPTION DRUG USER FEE ACT TO IMPROVE THE U.S. FOOD AND DRUG ADMINISTRATION'S (FDA'S) PROCESS FOR HUMAN DRUG REVIEW.- PROMOTED HEALTHCARE POLICIES THAT RECOGNIZE BOTH THE PROMISE AND VALUE OF INNOVATION.- ADVOCATED FOR A SAFE AND PREDICTABLE REGULATORY ENVIRONMENT FOR VALUE-BASED PAYMENT ARRANGEMENTS FOR DRUGS AND BIOLOGICS.- ENHANCED AND PROTECTED PATIENT ACCESS TO INNOVATIVE THERAPIES AND PROMOTED THE NEED FOR GREATER NONDISCRIMINATION ENFORCEMENT AGAINST INSURANCE BENEFIT DESIGNS.- ADVOCATED FOR BIOSIMILARS POLICIES THAT PROTECT PATIENT SAFETY, PROMOTE BIOMEDICAL INNOVATION, AND ADVANCE THE SCIENCE-BASED REVIEW AND APPROVAL OF BIOSIMILARS AND INTERCHANGEABLE BIOLOGICAL PRODUCTS.- PROMOTED THE VALUE OF U.S. GOVERNMENT INVESTMENTS IN PROGRAMS THAT IMPROVE ACCESS TO IMMUNIZATIONS AND FOSTER VACCINE INNOVATION, STRENGTHENED OUR ABILITY TO RESPOND TO BIOTERROR THREATS OR EMERGING INFECTIOUS DISEASES, AND ENCOURAGED DEVELOPMENT OF NEW PRODUCTS TO FIGHT ANTIMICROBIAL RESISTANCE (AMR).- INFLUENCED IMPROVEMENTS TO THE INTERNATIONAL ENVIRONMENT FOR BIOMEDICAL INNOVATION AND GLOBAL PUBLIC HEALTH PREPAREDNESS.THE EMERGING COMPANIES SECTION 2016 ADVOCACY ACCOMPLISHMENTS: - ADVANCED THE INTEREST OF EMERGING COMPANIES IN CAPITAL FORMATION AND FINANCIAL SERVICES POLICY.- ADVOCATED FOR TAX POLICIES SUPPORTING INNOVATIVE EMERGING COMPANIES AND INVESTMENT IN GROUNDBREAKING R&D; ENHANCED THE VOICE OF PRE-REVENUE, R&D-INTENSIVE BUSINESSES IN THE TAX REFORM DEBATE.- ADVOCATED FOR THE REMOVAL OF BURDENSOME FINANCIAL REPORTING REGULATIONS ON EMERGING COMPANIES.- SUPPORTED THE SEC SMALL BUSINESS ADVOCATE ACT TO ENHANCE THE ROLE OF SMALL BUSINESSES IN THE SEC'S DECISION-MAKING PROCESS, WHICH WAS SIGNED INTO LAW BY PRESIDENT OBAMA IN DECEMBER 2016.THE FOOD & AGRICULTURE SECTION 2016 ADVOCACY ACCOMPLISHMENTS: - SUCCESSFULLY ADVOCATED FOR PASSAGE OF THE NATIONAL BIOENGINEERED FOOD DISCLOSURE LAW - WORKED WITH THE ADMINISTRATION AND CONGRESS TO ADVANCE IMPROVEMENTS TO THE U.S. AND GLOBAL REGULATORY SYSTEMS FOR AG-BIOTECH PRODUCTS. - WORKED WITH MEMBERS OF THE AGRICULTURAL VALUE CHAIN TO ADDRESS TRADE ISSUES IN AGRICULTURAL EXPORT MARKETS SUCH AS CHINA AND EUROPE. - WORKED WITH AGRICULTURAL INDUSTRY ALLIES TO OPPOSE FEDERAL AND STATE-LEVEL INITIATIVES AIMED AT MANDATING GMO FOOD LABELING.- ADVOCATED IN LEGISLATURES AND COURTS TO PRESERVE THE RIGHTS OF FARMERS TO PLANT GENETICALLY ENGINEERED CROPS. THE INDUSTRIAL & ENVIRONMENTAL SECTION 2016 ADVOCACY ACCOMPLISHMENTS: - PRODUCED A RENEWABLE CHEMICALS REPORT TO CAPTURE THE BROAD SCOPE OF TECHNOLOGIES, PARTNERSHIPS, AND RAPID GROWTH OF THE RENEWABLE CHEMICALS SECTOR.- ADVOCATED FOR EPA TO TREAT ALL SUSTAINABLY SOURCED BIOMASS AS ELIGIBLE MEASURES FOR EMISSIONS REDUCTION CREDIT (ERC) GENERATION. - ADVOCATED REGARDING THE PASSAGE AND IMPLEMENTATION OF THE TOXIC SUBSTANCES CONTROL ACT (TSCA) AS AMENDED BY CONGRESS, AS WELL AS ISSUES RELATING TO THE NATIONAL BIOENGINEERED FOOD DISCLOSURE ACT.- ENGAGED WITH THE ADMINISTRATION'S REVIEW OF THE COORDINATED FRAMEWORK FOR BIOTECHNOLOGY, INCLUDING WITH RESPECT TO THE REGULATION OF GENETICALLY ENGINEERED (GE) ALGAE.- SUCCESSFULLY SECURED POSITIVE CHANGES TO EPA'S FINAL RENEWABLE FUEL STANDARDS (RFS) RULE FOR 2017. - URGED CONGRESS TO EXTEND A SUITE OF CRITICAL ADVANCED BIOFUELS TAX INCENTIVES BEYOND 2016. SERVICES: BIO'S SERVICES INCLUDE CONFERENCES AND ACTIVITIES THAT BRING TOGETHER INDUSTRY PARTNERS AND INVESTORS FOR EVENTS RANGING FROM THE BIO INTERNATIONAL CONVENTION TO CONFERENCES FOR BUSINESS DEVELOPMENT EXECUTIVES. THE BIO INTERNATIONAL CONVENTION ATTRACTS APPROXIMATELY 16,000 OF THE MOST INFLUENTIAL BIOTECH AND PHARMA ATTENDEES FROM 76 COUNTRIES AND 48 U.S. STATES, AS WELL AS THE DISTRICT OF COLUMBIA, PUERTO RICO AND THE US VIRGIN ISLANDS, INCLUDING 300 MEMBERS OF THE MEDIA, AND OFFERS THREE DAYS OF PROFESSIONAL AND BUSINESS DEVELOPMENT OPPORTUNITIES. THE NET INCOME FROM THE CONVENTION SUPPORTS OUR ADVOCACY, PUBLIC OUTREACH, AND OTHER MEMBER SERVICE ACTIVITIES. THE KEY ELEMENTS OF THE BIO INTERNATIONAL CONVENTION ARE EDUCATIONAL PROGRAMMING, EXHIBITION, THE BIO BUSINESS FORUM, AND NETWORKING EVENTS. THESE ELEMENTS PROVIDE AN OPPORTUNITY FOR BIOTECHNOLOGY AND PHARMACEUTICAL COMPANIES, ACADEMIC RESEARCH INSTITUTIONS, AND INVESTORS FROM AROUND THE WORLD TO LEARN ABOUT RECENT SCIENTIFIC AND POLICY DEVELOPMENTS, AND SCHEDULE ONE-ON-ONE MEETINGS TO DISCUSS POTENTIAL BUSINESS OPPORTUNITIES. IN 2016, THE BIO BUSINESS FORUM ALONE HELPED HOST A RECORD NUMBER OF OVER 35,700 PARTNERING MEETINGS AMONG MORE THAN 3,400 COMPANIES, ALONG WITH 192 COMPANY PRESENTATIONS, OVER 800 SPEAKERS, 1,800 EXHIBITIONS WITH 50 INTERNATIONAL, REGIONAL AND STATE PAVILIONS AND SEVEN PRODUCT FOCUS ZONES.BEYOND THE CONVENTION, BIO HOSTS OR CO-HOSTS A NUMBER OF NATIONAL AND INTERNATIONAL CONFERENCES THAT PROVIDE VENUES FOR MEMBER AND NON-MEMBER COMPANIES TO PRESENT NEW DATA, MEET AND PARTNER WITH FELLOW BIOTECH COMPANIES, AND ATTRACT FUNDING FROM INVESTORS AND OTHER ORGANIZATIONS. 0 0 0 1 0 0 0 0 0 1 0 0 0 1 0 1 0 0 0 1 0 0 0 0 0 0 1 0 1 0 0 0 0 1 0 0 0 0 0 0 0 0 0 1 157 0 210 1 1 1 1 IN 0 0 0 0 X 114 114 0 0 1 0 1 1 0 1 1 0 0 0 1 1 1 1 1 1 1 0 X YVETTE WHITE-WIGGINS 2029629200 1201 MARYLAND AVENUE SW SUITE 990 WASHINGTON DC 20024 RON COHEN MD CHAIRMAN 2.00 X X 0 0 0 DAVID P MEEKER MD SECRETARY 2.00 X X 0 0 0 BRADFORD A ZAKES TREASURER 2.00 X X 0 0 0 DANIEL JUNIUS TREASURER (PARTIAL YEAR) 2.00 X X 0 0 0 DEBORAH DUNSIRE MD SECRETARY (PARTIAL YEAR) 2.00 X X 0 0 0 ADAM MONROE BOARD MEMBER 2.00 X 0 0 0 ADELENE PERKINS BOARD MEMBER 2.00 X 0 0 0 ALAN SHAW BOARD MEMBER 2.00 X 0 0 0 ALBERT BOURLA BOARD MEMBER 2.00 X 0 0 0 ALEX AZAR BOARD MEMBER 2.00 X 0 0 0 ALLEN WAXMAN BOARD MEMBER 2.00 X 0 0 0 ANNA RATH BOARD MEMBER 2.00 X 0 0 0 BRIAN BARKER BOARD MEMBER 2.00 X 0 0 0 C DAVID NICHOLSON BOARD MEMBER 2.00 X 0 0 0 CARLOS PAYA BOARD MEMBER 2.00 X 0 0 0 CHRISTIAN NOLET BOARD MEMBER 2.00 X 0 0 0 CHRISTOPHER BOERNER BOARD MEMBER 2.00 X 0 0 0 CLIVE MEANWELL BOARD MEMBER 2.00 X 0 0 0 DAN MEAGHER BOARD MEMBER 2.00 X 0 0 0 DAPHNE PREUSS BOARD MEMBER 2.00 X 0 0 0 DAVID MAIN BOARD MEMBER 2.00 X 0 0 0 DAVID STACK BOARD MEMBER 2.00 X 0 0 0 DOUG BERVEN BOARD MEMBER 2.00 X 0 0 0 DOUGLAS DOERFLER BOARD MEMBER 2.00 X 0 0 0 EDDIE SULLIVAN BOARD MEMBER 2.00 X 0 0 0 ELI BEN-SHOSHAN BOARD MEMBER 2.00 X 0 0 0 ELIZABETH LEWIS BOARD MEMBER 2.00 X 0 0 0 EMIL KAKKIS BOARD MEMBER 2.00 X 0 0 0 FRANK TERHORST BOARD MEMBER 2.00 X 0 0 0 GARY PHILLIPS BOARD MEMBER 2.00 X 0 0 0 GARY ZIEZIULA BOARD MEMBER 2.00 X 0 0 0 GIL VAN BOKKELEN PHD BOARD MEMBER 2.00 X 0 0 0 GLENN GORMLEY BOARD MEMBER 2.00 X 0 0 0 HAROLD E VAN WART PHD BOARD MEMBER 2.00 X 0 0 0 HENRI A TERMEER BOARD MEMBER 2.00 X 0 0 0 HERVE HOPPENOT BOARD MEMBER 2.00 X 0 0 0 HOWARD ROBIN BOARD MEMBER 2.00 X 0 0 0 HUGH C WELSH JD BOARD MEMBER 2.00 X 0 0 0 IAN CLARK BOARD MEMBER 2.00 X 0 0 0 JACK BERNENS BOARD MEMBER 2.00 X 0 0 0 JAMES HEALY BOARD MEMBER 2.00 X 0 0 0 JAMES LEVINE BOARD MEMBER 2.00 X 0 0 0 JAMES SAPIRSTEIN BOARD MEMBER 2.00 X 0 0 0 JAMES SULLIVAN BOARD MEMBER 2.00 X 0 0 0 JAY SIEGEL BOARD MEMBER 2.00 X 0 0 0 JEAN-CHRISTOPHE TELLIER BOARD MEMBER 2.00 X 0 0 0 JEAN-CHRISTOPHE WESTPHAL BOARD MEMBER 2.00 X 0 0 0 JEAN-FRANCOIS FORMELA BOARD MEMBER 2.00 X 0 0 0 JEAN-JACQUES BIENAIME BOARD MEMBER 2.00 X 0 0 0 JEFFREY CLELAND BOARD MEMBER 2.00 X 0 0 0 JENNIFER HOLMGREN BOARD MEMBER 2.00 X 0 0 0 JEREMY LEVIN BOARD MEMBER 2.00 X 0 0 0 JERRY FLINT BOARD MEMBER 2.00 X 0 0 0 JIM MEYERS BOARD MEMBER 2.00 X 0 0 0 JOEL MARCUS BOARD MEMBER 2.00 X 0 0 0 JOHN CROWLEY BOARD MEMBER 2.00 X 0 0 0 JOHN GLASSPOOL BOARD MEMBER 2.00 X 0 0 0 JOHN MARAGANORE BOARD MEMBER 2.00 X 0 0 0 JOHN MELO BOARD MEMBER 2.00 X 0 0 0 JOHN MENDLEIN BOARD MEMBER 2.00 X 0 0 0 JOHN ORWIN BOARD MEMBER 2.00 X 0 0 0 JOHN SWART BOARD MEMBER 2.00 X 0 0 0 JONATHAN LEFF BOARD MEMBER 2.00 X 0 0 0 JONATHAN WOLFSON BOARD MEMBER 2.00 X 0 0 0 JOSEPH LAROSA BOARD MEMBER 2.00 X 0 0 0 JOSEPH SHAULSON BOARD MEMBER 2.00 X 0 0 0 JULIE GERBERDING BOARD MEMBER 2.00 X 0 0 0 KATHLEEN TREGONING BOARD MEMBER 2.00 X 0 0 0 KATRINE BOSLEY BOARD MEMBER 2.00 X 0 0 0 KIRAN MAZUMDAR-SHAW BOARD MEMBER 2.00 X 0 0 0 MARK ALLES BOARD MEMBER 2.00 X 0 0 0 MARK ENYEDY BOARD MEMBER 2.00 X 0 0 0 MARK JONES BOARD MEMBER 2.00 X 0 0 0 MARK PRUZANSKI BOARD MEMBER 2.00 X 0 0 0 MARK SKALETSKY BOARD MEMBER 2.00 X 0 0 0 MARK TIMNEY BOARD MEMBER 2.00 X 0 0 0 MARKUS POMPEJUS BOARD MEMBER 2.00 X 0 0 0 MARTIN BABLER BOARD MEMBER 2.00 X 0 0 0 MAXINE GOWEN BOARD MEMBER 2.00 X 0 0 0 MICHAEL KNUTZEN BOARD MEMBER 2.00 X 0 0 0 MICHAEL NARACHI BOARD MEMBER 2.00 X 0 0 0 MICHAEL RAAB BOARD MEMBER 2.00 X 0 0 0 MICHELLE DIPP BOARD MEMBER 2.00 X 0 0 0 MONCEF SLAOUI BOARD MEMBER 2.00 X 0 0 0 NANCY SIMONIAN BOARD MEMBER 2.00 X 0 0 0 NEIL GOLDSMITH BOARD MEMBER 2.00 X 0 0 0 NEIL K WARMA BOARD MEMBER 2.00 X 0 0 0 NICK LESCHLY BOARD MEMBER 2.00 X 0 0 0 PAUL EISENBERG BOARD MEMBER 2.00 X 0 0 0 PAUL HASTINGS BOARD MEMBER 2.00 X 0 0 0 PERRY KARSEN BOARD MEMBER 2.00 X 0 0 0 PETER GREENLEAF BOARD MEMBER 2.00 X 0 0 0 PHILIP MILLER BOARD MEMBER 2.00 X 0 0 0 PAUL BACKMAN BOARD MEMBER 2.00 X 0 0 0 RACHEL KING BOARD MEMBER 2.00 X 0 0 0 RICHARD POPS BOARD MEMBER 2.00 X 0 0 0 RICK VAN GENDEREN BOARD MEMBER 2.00 X 0 0 0 RICK WINNINGHAM BOARD MEMBER 2.00 X 0 0 0 ROBERT REPELLA BOARD MEMBER 2.00 X 0 0 0 ROBERT WILLS BOARD MEMBER 2.00 X 0 0 0 RONALD STOTISH BOARD MEMBER 2.00 X 0 0 0 RUSSELL HERNDON BOARD MEMBER 2.00 X 0 0 0 SANDY MACRAE BOARD MEMBER 2.00 X 0 0 0 SABINE LUIK BOARD MEMBER 2.00 X 0 0 0 SCOTT HOLMSTROM BOARD MEMBER 2.00 X 0 0 0 SCOTT KOENIG BOARD MEMBER 2.00 X 0 0 0 STEVEN MENTO BOARD MEMBER 2.00 X 0 0 0 STEVEN PAUL BOARD MEMBER 2.00 X 0 0 0 STUART A ARBUCKLE BOARD MEMBER 2.00 X 0 0 0 THOMAS MATHERS BOARD MEMBER 2.00 X 0 0 0 THOMAS WIGGANS BOARD MEMBER 2.00 X 0 0 0 TIMOTHY P WALBERT BOARD MEMBER 2.00 X 0 0 0 TJERK DE RUITER BOARD MEMBER 2.00 X 0 0 0 WILLIAM FIZSIMMONS BOARD MEMBER 2.00 X 0 0 0 WILLIAM HINSHAW BOARD MEMBER 2.00 X 0 0 0 WILLIAM NEWELL BOARD MEMBER 2.00 X 0 0 0 ADRIAN ADAMS BOARD MEMBER (PARTIAL YEAR) 2.00 X 0 0 0 ARLENE MORRIS BOARD MEMBER (PARTIAL YEAR) 2.00 X 0 0 0 BILL LIS BOARD MEMBER (PARTIAL YEAR) 2.00 X 0 0 0 BRADLEY A SHURDUT ESQ BOARD MEMBER (PARTIAL YEAR) 2.00 X 0 0 0 CENAN OZMERAL BOARD MEMBER (PARTIAL YEAR) 2.00 X 0 0 0 CHRISTI L SHAW BOARD MEMBER (PARTIAL YEAR) 2.00 X 0 0 0 CHRISTOPHER STANDLEE BOARD MEMBER (PARTIAL YEAR) 2.00 X 0 0 0 DANIEL APEL BOARD MEMBER (PARTIAL YEAR) 2.00 X 0 0 0 DANIEL CUMMINGS BOARD MEMBER (PARTIAL YEAR) 2.00 X 0 0 0 DANIEL TASSE BOARD MEMBER (PARTIAL YEAR) 2.00 X 0 0 0 DAVID HALLAL BOARD MEMBER (PARTIAL YEAR) 2.00 X 0 0 0 DAVID PYOTT BOARD MEMBER (PARTIAL YEAR) 2.00 X 0 0 0 DAVID SCHENKEIN MD BOARD MEMBER (PARTIAL YEAR) 2.00 X 0 0 0 EDWARD WILLIAMS BOARD MEMBER (PARTIAL YEAR) 2.00 X 0 0 0 FAHEEM HASNAIN BOARD MEMBER (PARTIAL YEAR) 2.00 X 0 0 0 FLEMING ORNSKOV BOARD MEMBER (PARTIAL YEAR) 2.00 X 0 0 0 GENO GERMANO BOARD MEMBER (PARTIAL YEAR) 2.00 X 0 0 0 H THOMAS WATKINS BOARD MEMBER (PARTIAL YEAR) 2.00 X 0 0 0 HABIB DABLE BOARD MEMBER (PARTIAL YEAR) 2.00 X 0 0 0 HANS SCHIKAN BOARD MEMBER (PARTIAL YEAR) 2.00 X 0 0 0 JEFFREY HANKE BOARD MEMBER (PARTIAL YEAR) 2.00 X 0 0 0 JEFFREY HATFIELD BOARD MEMBER (PARTIAL YEAR) 2.00 X 0 0 0 JEFFREY WREN BOARD MEMBER (PARTIAL YEAR) 2.00 X 0 0 0 JOHN MILLIGAN BOARD MEMBER (PARTIAL YEAR) 2.00 X 0 0 0 JOSEF APPEL BOARD MEMBER (PARTIAL YEAR) 2.00 X 0 0 0 KLEANTHIS XANTHOPOULOUS BOARD MEMBER (PARTIAL YEAR) 2.00 X 0 0 0 KRISTINE PETERSON BOARD MEMBER (PARTIAL YEAR) 2.00 X 0 0 0 MARC BEER BOARD MEMBER (PARTIAL YEAR) 2.00 X 0 0 0 MARC VERBRUGGEN PHD BOARD MEMBER (PARTIAL YEAR) 2.00 X 0 0 0 MATTHIAS MEDER BOARD MEMBER (PARTIAL YEAR) 2.00 X 0 0 0 MICHAEL SEVERINO MD BOARD MEMBER (PARTIAL YEAR) 2.00 X 0 0 0 PARIS PANAYIOTOPOULOS BOARD MEMBER (PARTIAL YEAR) 2.00 X 0 0 0 PATRICK GRUBER BOARD MEMBER (PARTIAL YEAR) 2.00 X 0 0 0 PAUL HUDSON BOARD MEMBER (PARTIAL YEAR) 2.00 X 0 0 0 PONSI TRIVISVAVET BOARD MEMBER (PARTIAL YEAR) 2.00 X 0 0 0 RAYMOND SACCHETTI BOARD MEMBER (PARTIAL YEAR) 2.00 X 0 0 0 ROBERT KISS BOARD MEMBER (PARTIAL YEAR) 2.00 X 0 0 0 ROBIN READNOUR BOARD MEMBER (PARTIAL YEAR) 2.00 X 0 0 0 ROGER WYSE BOARD MEMBER (PARTIAL YEAR) 2.00 X 0 0 0 STANLEY T CROOKE BOARD MEMBER (PARTIAL YEAR) 2.00 X 0 0 0 STEPHAN B TANDA BOARD MEMBER (PARTIAL YEAR) 2.00 X 0 0 0 STEVEN H HOLTZMAN BOARD MEMBER (PARTIAL YEAR) 2.00 X 0 0 0 WILLIAM FEEHERY BOARD MEMBER (PARTIAL YEAR) 2.00 X 0 0 0 WILLIAM LIS BOARD MEMBER (PARTIAL YEAR) 2.00 X 0 0 0 JAMES GREENWOOD PRESIDENT & CHIEF EXECUTIVE OFFICER 40.00 X 2167665 0 679191 YVETTE WHITE-WIGGINS SVP & CHIEF FINANCIAL OFFICER 40.00 X 285042 0 61304 A SCOTT WHITAKER COO (PARTIAL YEAR) 40.00 X 378365 0 6100 THOMAS DILENGE PRESIDENT, ADVOCACY, LAW & PUBLIC POLICY DIV 40.00 X 604209 0 64621 JOANNE DUNCAN PRESIDENT, MEMBERSHIP & BUS OPER DIVISION 40.00 X 548530 0 60802 AMY FINAN SVP, BUSINESS DEV (PARTIAL YEAR) 40.00 X 221285 0 5499 KATHLEEN HOLCOMBE SVP, SCIENCE POLICY 40.00 X 425151 0 34286 DANIEL DURHAM EVP, HEALTH POLICY 40.00 X 457292 0 48380 BRENT ERICKSON EVP, INDUSTRIAL & ENVIRONMENT 40.00 X 508453 0 50536 JOSEPH DAMOND SVP, INTERNATIONAL AFFAIRS 40.00 X 469065 0 65176 ELIZABETH ESHAM EVP, ECS & VP, SCIENCE & REGULATORY 40.00 X 410493 0 46146 6475550 0 1122041 88 0 1 0 WHITE64 8603 WESTWOOD CENTER DRIVE 4TH FLO TYSONS VA 22182 COMMUNICATION SERVICES 3637817 FREEMAN EXPOSITIONS PO BOX 660613 DALLAS TX 75266 CONVENTION & CONFERENCES GENERAL CONTRAC 2429567 SMG FOOD & BEVERAGE 300 CONSHOHOCHEN STATE ROAD WEST CONSHOSHOCHEN PA 19428 CATERING 1778324 PROJECTION INC PO BOX 890472 CHARLOTTE NC 28289 AV 987425 MCCALL & ASSOC EVENTS MANAGEMENT INC 350 FLORIDA STREET SAN FRANCISCO CA 94110 EVENT MANAGEMENT 872995 94 CONFERENCE/MEETING REVENUE 541800 36266250 35903378 362872 MEMBERSHIP DUES 900099 27980251 27980251 INTERNATIONAL EFFORTS 900099 321119 321119 ALLIANCE/OUTREACH SUPPORT 900099 263041 263041 64830661 1712494 1712494 8671027 8671027 36959 36959 0 52415 52213 202 202 202 LEGAL 900099 648068 648068 EPF MEMBER SUPPORT 900099 500000 500000 POLICY SUPPORT 900099 244000 244000 308958 150000 48696 110262 1701026 76915410 66009857 411568 10493985 X 596583 5082613 21261323 1168393 2813420 1330059 1043520 67104 2699234 57103 12324820 320067 858339 1434956 4119901 1537522 16599092 5308 3198613 691793 135749 DUES & SUBSCRIPTIONS 1107420 OUTREACH 511460 BIO LEGISLATIVE DAY/FLY 190343 TAXES PAID 161239 58703 79374677 61943 5985669 12937952 2007963 2130779 3306569 2095808 2073003 10206672 8633777 1810704 1572895 54290166 58032455 125448 343753 73452800 73322307 15615548 17667769 12736910 11510981 4886185 4361446 33238643 33540196 X 40214157 39782111 40214157 39782111 73452800 73322307 X -2459267 2027221 0 X 0 1 X 1 0 0 0 1 27980251 9095951 -428871 8667080 9233483 -566403 6183915 5124316 1059599 788262 736242 52020 3234495 2773219 461276 1572895 CAPITAL LEASE OBLIGATION 54437 DEFERRED RENT 4307009 4361446 82510645 2027221 3588158 5615379 76895266 57103 -36959 20144 76915410 82942691 3625117 3625117 79317574 57103 57103 79374677 PART XI, LINE 2D - OTHER ADJUSTMENTS: FOOD & AG SGR FUND 2,815,701. FOOD & AG LEGAL FUND 81,494. BIOSIMILARS REVENUE 405,963. FGR SPECIAL INITIATIVES REVENUE 285,000. PART XI, LINE 4B - OTHER ADJUSTMENTS: RENTAL EXPENSES -36,959. PART XII, LINE 2D - OTHER ADJUSTMENTS: FOOD & AG LEGAL FUND EXPENSES 81,494. BIOSIMILAR EXPENSES 405,963. RENTAL EXPENSES 36,959. FGR SPECIAL INITIATIVE EXPENSES 285,000. FOOD & AG SGR FUND 2,815,701. 1 EAST ASIA AND THE PACIFIC - AUSTRALIA, BRUNEI, BURMA, CAMBODIA, 0 4 PROGRAM SERVICES CONFERENCES, ADVOCACY AND EDUCATION 350737 EUROPE (INCLUDING ICELAND & GREENLAND) - ALBANIA, ANDORRA, AUSTRIA, BELGIUM 0 2 PROGRAM SERVICES CONFERENCES, ADVOCACY AND EDUCATION 238389 MIDDLE EAST AND NORTH AFRICA 0 0 PROGRAM SERVICES ADVOCACY 2500 NORTH AMERICA - CANADA AND MEXICO, BUT NOT THE UNITED STATES 0 0 PROGRAM SERVICES ADVOCACY 47137 SOUTH AMERICA - ARGENTINA, BOLIVIA, BRAZIL, CHILE, COLUMBIA, ECUADOR, 0 2 PROGRAM SERVICES CONFERENCES, ADVOCACY AND EDUCATION 188301 SOUTH ASIA - AFGHANISTAN, BANGLADESH, BHUTAN, INDIA, MALDIVES, NEPAL, 0 2 PROGRAM SERVICES EDUCATION AND ADVOCACY 2553 0 10 0 0 0 10 829617 0 829617 0 0 0 0 0 0 PART I, LINE 2: THE ORGANIZATION HAS SUPPORTING DOCUMENTATION FOR THE AMOUNT THAT IS INVOICED FROM THE COMPANIES. 1 AIDS INSTITUTE PO BOX 34043 BETHESDA MD 208270043 030458239 501(C)(3) 7000 GENERAL SUPPORT ALLIANCE FOR AGING RESEARCH 507 CAPITOL COURT NE SUITE 200 WASHINGTON DC 20002 521316086 501(C)(3) 15000 GENERAL SUPPORT ALLIANCE FOR LUPUS RESEARCH PO BOX 465 ENCAMPMENT WY 82325 830264665 501(C)(3) 5000 SPONSORSHIP ALS ASSOCIATION 1275 K STREET NW SUITE 1050 WASHINGTON DC 20005 133271855 501(C)(3) 7000 SPONSORSHIP AMERICAN CANCER SOCIETY ACTION NETWORK 55 KENOSIA AVENUE DANBURY CT 06810 133223946 501(C)(3) 5000 GENERAL SUPPORT AMERICAN ENTERPRISE INSTITUTE FOR PUBLIC POLICY RESEARCH 1789 MASSACHUSETTS AVENUE NW WASHINGTON DC 20036 530218495 501(C)(3) 25000 GENERAL SUPPORT AMERICAN FARM BUREAU 750 17TH STREET NW SUITE 110 WASHINGTON DC 20006 541379174 501(C)(3) 7500 SPONSORSHIP AMERICAN HEART ASSOCIATION 515 NORTH MIDLAND AVENUE UPPER NYACK NY 10960 204039120 501(C)(3) 50000 SPONSORSHIP C-CHANGE 9160 SOUTH 300 WEST 21 SANDY UT 84070 870509416 501(C)(3) 15000 GENERAL SUPPORT CAREGIVER ACTION NETWORK 200 MARYLAND AVENUE NE WASHINGTON DC 20002 520796820 501(C)(3) 5000 SPONSORSHIP CITIZENS FOR A RESPONSIBLE BOLDER PO BOX 2371 ALEXANDRIA VA 22301 710874241 501(C)(3) 15000 SPONSORSHIP EPILEPSY FOUNDATION 901 E STREET NW SUITE 405 WASHINGTON DC 20004 311581756 501(C)(3) 10000 GENERAL SUPPORT EVERYLIFE FOUNDATION FOR RARE DISEASES 2000 N BEAUREGARD STREET 6TH FLOOR ALEXANDRIA VA 22311 131614906 501(C)(3) 10000 SPONSORSHIP FRIENDS OF CANCER RESEARCH 330 7TH AVENUE SUITE 1701 NEW YORK NY 10001 061565950 501(C)(3) 5000 SPONSORSHIP GALIEN FOUNDATION 99 JOHN STREET SUITE 2502 NEW YORK NY 10038 264549935 501(C)(3) 20000 SPONSORSHIP GLOBAL GENES PO BOX 791139 BALTIMORE MD 212791139 521694732 501(C)(3) 20833 SPONSORSHIP GROWTH ENERGY PO BOX 30273 OMAHA NE 68103 263542537 501(C)(6) 20000 CONTRIBUTION JDRF INTERNATIONAL 1200 NEW HAMPSHIRE AVENUE NW SUITE 575 WASHINGTON DC 20036 311750942 501(C)(3) 8750 SPONSORSHIP LEADERS OF AMERICAN AGRICULTURE 4720 MONTGOMERY LANE SUITE 205 BETHESDA MD 20814 521931357 501(C)(3) 5000 SPONSORSHIP MELANO RESEARCH ALLIANCE FOUNDATION 1101 NEW YORK AVENUE SUITE 620 WASHINGTON DC 20005 261636099 501(C)(3) 10000 SPONSORSHIP MICHAEL J FOX FOUNDATION 52 VANDERBILT AVENUE NEW YORK NY 10017 132912529 501(C)(3) 5000 GENERAL SUPPORT NAT'L ORG FOR RARE DISORDERS 1025 VERMONT AVENUE SUITE 1120 WASHINGTON DC 20005 943172675 501(C)(3) 5000 SPONSORSHIP NATIONAL ALLIANCE OF STATE AND TERRITORIAL 5845 RICHMOND HIGHWAY SUITE 800 ALEXANDRIA VA 22303 135644916 501(C)(3) 10000 GENERAL SUPPORT NATIONAL ALLIANCE ON MENTAL ILLNESS 750 FIRST STREET NW 7TH FLOOR WASHINGTON DC 20002 113485631 501(C)(3) 5000 GENERAL SUPPORT NATIONAL FARMERS UNION 4699 MURPHY CANYON ROAD SAN DIEGO CA 92123 952644377 501(C)(3) 10000 SPONSORSHIP NATIONAL HEALTH COUNCIL 1730 M STREET NW SUITE 500 WASHINGTON DC 200364561 131624107 501(C)(3) 25000 SPONSORSHIP NATIONAL OILSEED PROCESSORS 5005 LBJ TEXAS FREEWAY SUITE 250 DALLAS TX 75244 751835298 501(C)(3) 7500 SPONSORSHIP PARENT PROJECT MUSCULAR DYSTROPHY 101 YGNACIO VALLEY ROAD SUITE 110 WALNUT CREEK CA 94596 131788491 501(C)(3) 20000 SPONSORSHIP PARKINSON'S ACTION NETWORK 1025 VERMONT AVENUE SUITE 1120 WASHINGTON DC 20005 943172675 501(C)(3) 7000 SPONSORSHIP PREVENT CANCER FOUNDATION 1600 DUKE STREET SUITE 500 ALEXANDRIA VA 22314 521429544 501(C)(3) 5000 SPONSORSHIP REAGAN-UDALL FOUNDATION FOR FDA 1025 CONNECTICUT AVENUE NW SUITE 1000 WASHINGTON DC 20036 263727917 501(C)(3) 5000 SPONSORSHIP RETIRESAFE 1101 NEW YORK AVENUE SUITE 620 WASHINGTON DC 20006 261636099 501(C)(3) 5000 SPONSORSHIP SOCIETY FOR WOMENS HEALTH 1600 DUKE STREET SUITE 500 ALEXANDRIA VA 22314 521429544 501(C)(3) 15000 SPONSORSHIP THE CONGRESSIONAL HUNGER CENTER 701 SW 27TH AVENUE SUITE 705 MIAMI FL 33135 592767754 501(C)(3) 10000 SPONSORSHIP THE MILKEN INSTITUTE 750 9TH STREET NW SUITE 750 WASHINGTON DC 20001 264614274 501(C)(3) 25000 GENERAL SUPPORT US CHAMBER OF COMMERCE 1101 K STREET SUITE 610 WASHINGTON DC 20005 530045720 501(C)(3) 166000 MEMBERSHIP AND GENERAL SUPPORT UTAH FAMILIES FOUNDATION 678 EAST VINE STREET MURRAY UT 84107 870509416 501(C)(3) 5000 SPONSORSHIP 36 1 PART I, LINE 2: BIO RELIES ON THE REQUIRED QUALIFICATIONS OF THE GRANT RECIPIENTS TO PROVIDE ASSURANCE OF PROPER USAGE. IN SOME CASES, BIO PERSONNEL ATTEND EVENTS AND RECEIVE ACKNOWLEDGEMENTS RELATED TO THE FUNDS GRANTED. X X X 0 1 X X X X X 0 1 0 JAMES GREENWOOD PRESIDENT & CHIEF EXECUTIVE OFFICER 1345294 0 778371 0 44000 0 608411 0 70780 0 2846856 0 0 0 YVETTE WHITE-WIGGINS SVP & CHIEF FINANCIAL OFFICER 255042 0 30000 0 0 0 32319 0 28985 0 346346 0 0 0 A SCOTT WHITAKER COO (PARTIAL YEAR) 130153 0 214570 0 33642 0 0 0 6100 0 384465 0 0 0 THOMAS DILENGE PRESIDENT, ADVOCACY, LAW & PUBLIC PO 455803 0 148406 0 0 0 35000 0 29621 0 668830 0 0 0 JOANNE DUNCAN PRESIDENT, MEMBERSHIP & BUS OPER DIV 431966 0 116564 0 0 0 35000 0 25802 0 609332 0 0 0 AMY FINAN SVP, BUSINESS DEV (PARTIAL YEAR) 95475 0 111316 0 14494 0 2492 0 3007 0 226784 0 0 0 KATHLEEN HOLCOMBE SVP, SCIENCE POLICY 320779 0 104372 0 0 0 32426 0 1860 0 459437 0 0 0 DANIEL DURHAM EVP, HEALTH POLICY 407292 0 50000 0 0 0 28225 0 20155 0 505672 0 0 0 BRENT ERICKSON EVP, INDUSTRIAL & ENVIRONMENT 381753 0 126700 0 0 0 35000 0 15536 0 558989 0 0 0 JOSEPH DAMOND SVP, INTERNATIONAL AFFAIRS 351542 0 117523 0 0 0 35000 0 30176 0 534241 0 0 0 ELIZABETH ESHAM EVP, ECS & VP, SCIENCE & REGULATORY 315000 0 95493 0 0 0 35000 0 11146 0 456639 0 0 0 PART I, LINE 1A JAMES GREENWOOD: - NOT INCLUDED IN TAXABLE COMPENSATION TO THE INDIVIDUAL: - FIRST CLASS OR CHARTER TRAVEL - $20,334 - INCLUDED IN TAXABLE COMPENSATION TO THE INDIVIDUAL: - TRAVEL FOR COMPANIONS - $7,020 PART I, LINE 1B THE CHIEF EXECUTIVE OFFICER HAS A PREPAID SPENDING ACCOUNT AT A LOCAL RESTAURANT, USED EXCLUSIVELY FOR BUSINESS PURPOSES. PART I, LINE 4B JAMES GREENWOOD - 457(F) $573,411 LAURA GREENWOOD DAUGHTER OF CEO 59060 PAID EMPLOYEE OF ORGANIZATION 0 FORM 990, PART VI, SECTION A, LINE 1 THE BOARD OF DIRECTORS SHALL DESIGNATE, BY RESOLUTION AND WITH A QUORUM PRESENT, NOT MORE THAN NINETEEN (19) DIRECTORS OF THE BOARD TO ACT AS AN EXECUTIVE COMMITTEE. THE EXECUTIVE COMMITTEE SHALL CONSIST OF THE SEVEN (7) ELECTED OFFICERS OF THE ORGANIZATION (AS DEFINED IN ARTICLE VIII); THE IMMEDIATE PAST CHAIR OF THE ORGANIZATION; THE VICE CHAIRS OF EACH SECTION'S GOVERNING BOARD; AND THE BALANCE BEING AT-LARGE DIRECTORS FROM THE FULL BOARD. IF THE IMMEDIATE PAST CHAIR IS NO LONGER ELIGIBLE TO SERVE ON THE FULL BOARD, AN ADDITIONAL AT-LARGE DIRECTOR FROM THE FULL BOARD SHALL BE SELECTED FOR THE EXECUTIVE COMMITTEE. THE EXECUTIVE COMMITTEE SHALL HAVE, AND BE AUTHORIZED TO EXERCISE, ALL POWERS OF THE FULL BOARD, EXCEPT: (A) THE POWER TO ELECT OR REMOVE ELECTED OFFICERS OR DIRECTORS, TO CHANGE THE SIZE OF THE BOARD, TO CHANGE ELIGIBILITY, QUALIFICATIONS OR RIGHTS OF MEMBERSHIP, TO APPROVE THE FINANCIAL BUDGET FOR THE ORGANIZATION, OR TO MAKE DETERMINATIONS AS TO DIRECTOR AND OFFICER COMPENSATION, WHERE APPLICABLE; AND (B) THE POWER TO AMEND THE ARTICLES OF INCORPORATION OR THE BYLAWS OF THE ORGANIZATION. FORM 990, PART VI, SECTION A, LINE 4 THE BIOTECHNOLOGY INDUSTRY ORGANIZATION OFFICIALLY CHANGED ITS NAME TO THE BIOTECHNOLOGY INNOVATION ORGANIZATION ON JANUARY 5, 2016. AS A RESULT, THE BYLAWS FOR THE FULL BIO BOARD OF DIRECTORS AND THE FOUR BIO SECTIONS MUST BE AMENDED TO REFLECT THAT CHANGE. THE BYLAWS AMENDMENTS WERE PRESENTED AND FORMALLY APPROVED BY THE BIO GOVERNANCE & COMPLIANCE COMMITTEE AT ITS MEETING ON MAY 9, 2016. REVISION OF BYLAWS WAS ISSUED ON JUNE 6, 2016. FORM 990, PART VI, SECTION A, LINE 6 THE MEMBERS OF THE ORGANIZATION SHALL BE DIVIDED INTO FOUR CLASSES; CORE MEMBERS, ASSOCIATE MEMBERS, AFFILIATE MEMBERS, AND CENTER MEMBERS, DEFINED AS FOLLOWS: (A) CORE MEMBERS: ANY CORPORATION, PARTNERSHIP, ASSOCIATION, OR OTHER ENTITY ORGANIZED FOR PROFIT, A SUBSTANTIAL PERCENTAGE OF WHOSE BUSINESS ACTIVITIES INVOLVE BIOTECHNOLOGY, GENOMICS, BIOINFORMATICS OR RELATED NEW TECHNOLOGIES, IS ELIGIBLE FOR MEMBERSHIP. CORE MEMBERS ARE THOSE ENTITIES THAT UTILIZE BIOTECHNOLOGY, GENOMICS, BIOINFORMATICS OR OTHER RELATED NEW TECHNOLOGIES IN RESEARCH, DEVELOPMENT, TESTING, MANUFACTURING, OR SALES OF PRODUCT OR INFORMATION, AS WELL AS OTHER FIRMS THE BOARD SO CHARACTERIZES AND PLACES IN THIS CATEGORY. CORE MEMBERS SHALL BE GROUPED IN THE FOLLOWING SUBCATEGORIES: (I) EMERGING COMPANIES, WHICH ARE FIRMS THAT EMPLOY LESS THAN 350 PERSONS AND THAT DO NOT HAVE A THERAPEUTIC OR DIAGNOSTIC PRODUCT APPROVED FOR SALE IN THE U.S. MARKET; (II) ESTABLISHED FIRMS, WHICH ARE THOSE FIRMS THAT EMPLOY 350 OR MORE PERSONS OR THAT HAVE A THERAPEUTIC OR DIAGNOSTIC PRODUCT APPROVED FOR SALE IN THE U.S. MARKET; AND (III) LARGE FIRMS, WHICH ARE ESTABLISHED FIRMS THAT HAVE ANNUAL WORLDWIDE SALES OF BIOTECHNOLOGY PRODUCTS IN EXCESS OF $1.5 BILLION; AND (IV) NON-DOMESTIC COMPANIES, WHICH ARE CORE MEMBERS WITHOUT SIGNIFICANT OPERATIONS IN THE UNITED STATES OR SIGNIFICANT COLLABORATIONS WITH A U.S. ENTITY. (B) ASSOCIATE MEMBERS: ANY CORPORATION, PARTNERSHIP, ASSOCIATION, OR OTHER ENTITY ORGANIZED FOR PROFIT, A SUBSTANTIAL PORTION OF WHOSE ACTIVITIES INVOLVE PROVIDING SERVICES OR PRODUCTS OF BENEFIT TO COMPANIES WHOSE PRINCIPAL BUSINESS IS BIOTECHNOLOGY, IS ELIGIBLE FOR ASSOCIATE MEMBERSHIP. ASSOCIATE MEMBERS ARE THOSE COMMERCIAL ENTITIES WHICH DO NOT NECESSARILY UTILIZE BIOTECHNOLOGY; E.G. TECHNICAL SUPPORT, EQUIPMENT, CONSTRUCTION, ACCOUNTING, AND LAW FIRMS THAT SERVICE THE BIOTECHNOLOGY INDUSTRY, AS WELL AS OTHER FIRMS THAT THE BOARD CHARACTERIZES AND PLACES IN THIS CATEGORY. (C) AFFILIATE MEMBERS: ANY GOVERNMENTAL OR NONPROFIT ENTITY OR COUNTRY, STATE OR REGIONAL INDUSTRY, TRADE OR PROFESSIONAL ASSOCIATION WITH AN INTEREST IN, OR A MANDATE TO PROMOTE THE DEVELOPMENT OF, BIOTECHNOLOGY IS ELIGIBLE FOR AFFILIATE MEMBERSHIP. THERE SHALL BE NO SIZE TESTS APPLIED TO AFFILIATE MEMBER APPLICANTS. (D) CENTER MEMBERS: ANY INSTITUTION, NOT GENERALLY ELIGIBLE FOR CORE MEMBERSHIP THAT IS SPONSORED BY A STATE, REGION, OR ACADEMIC INSTITUTION AND WORKS IN SUPPORT OF COMMERCIAL BIOTECHNOLOGY MAY BE ELIGIBLE FOR CONSIDERATION AS A CENTER MEMBER. FORM 990, PART VI, SECTION A, LINE 7A AT ALL MEMBERSHIP MEETINGS OF THE ORGANIZATION, EACH CURRENT MEMBER SHALL HAVE ONE (1) VOTE AND MAY TAKE PART IN THE VOTING IN PERSON OR BY PROXY. FOR EACH SECTION IN WHICH THE MEMBER PARTICIPATES, EACH MEMBER SHALL HAVE THE RIGHT TO VOTE ON THE ELECTION OF DIRECTORS FOR THE SECTION GOVERNING BOARD, BUT SHALL HAVE NO OTHER VOTING RIGHTS EXCEPT ON MATTERS BROUGHT TO THE MEMBERSHIP BY ANY SUCH GOVERNING BOARD OR THE ORGANIZATION'S BOARD OF DIRECTORS. FORM 990, PART VI, SECTION B, LINE 11B THE FORM 990 AND RELATED SCHEDULES ARE PREPARED BY THE ORGANIZATION'S CERTIFIED PUBLIC ACCOUNTANTS UNDER THE GUIDANCE OF THE CHIEF FINANCIAL OFFICER (CFO). THE CFO AND THE CONTROLLER THOROUGHLY REVIEW ALL CALCULATIONS AND SCHEDULES TO CONFIRM THEY REFLECT THE ACTUAL FINANCIAL RESULTS OF THE ORGANIZATION. THE COMPLETE FORM 990 IS THEN REVIEWED INTERNALLY BY THE CEO, DIVISION PRESIDENTS, CFO, AND CONTROLLER IN CONSULTATION WITH LEGAL COUNSEL AND, AS APPROPRIATE, FURTHER CONSULTATION WITH THE ORGANIZATION'S CERTIFIED PUBLIC ACCOUNTANTS. FINALLY, THE FORM 990 IS PROVIDED TO THE CHAIRMAN OF THE BOARD AND BIO EXECUTIVE COMMITTEE MEMBERS FOR THEIR REVIEW, QUESTIONS AND/OR COMMENTS. ALL REVIEWS ARE COMPLETED BEFORE THE FORM IS FILED WITH THE IRS. FORM 990, PART VI, SECTION B, LINE 12C BIOTECHNOLOGY INNOVATION ORGANIZATION (BIO) TAKES SEVERAL STEPS TO ADDRESS COMPLIANCE BY EMPLOYEES AND DIRECTORS WITH ITS CONFLICTS OF INTEREST POLICY. BIO TRAINS ALL NEW EMPLOYEES AND DIRECTORS ON VARIOUS ASPECTS OF BIO'S COMPLIANCE PROGRAM, INCLUDING CONFLICTS OF INTEREST, AND BIO'S WRITTEN CONFLICTS OF INTEREST POLICY REQUIRES ALL EMPLOYEES TO DISCLOSE ANY OUTSIDE PERSONAL BUSINESS INTERESTS TO THEIR SUPERVISOR. BIO'S GENERAL COUNSEL REGULARLY ADVISES BIO'S EXECUTIVES AND SUPERVISORS ON SUCH MATTERS. BIO ALSO CONTRACTS WITH AN INDEPENDENT ORGANIZATION TO PROVIDE EMPLOYEES AND OTHERS WITH THE ABILITY TO FILE ANONYMOUS REPORTS CONCERNING THE VIOLATION OF ANY LAWS OR BIO POLICIES, INCLUDING ALLEGATIONS OF POTENTIAL CONFLICTS OF INTEREST, AND BIO HAS A PROCESS IN PLACE TO FOLLOW UP ON ANY SUCH COMPLAINTS IN A TIMELY AND THOROUGH MANNER. FURTHER, BIO UNDERTAKES A QUESTIONNAIRE SENT TO EACH MEMBER OF ITS BOARD OF DIRECTORS SEEKING DISCLOSURE OF ANY POTENTIAL CONFLICTS OF INTERESTS THEY MAY HAVE, OR THEIR FAMILY MEMBERS MAY HAVE, ASSOCIATED WITH BUSINESSES OR ORGANIZATIONS THAT DO BUSINESS WITH BIO. POTENTIAL CONFLICTS ARE MONITORED AND REVIEWED AT THE MANAGEMENT AND SENIOR MANAGEMENT LEVEL OF THE ORGANIZATION, AND DEPENDING ON THE CONFLICT, DETERMINATIONS MAY BE MADE AT THE BOARD OR SENIOR MANAGEMENT LEVEL. A CONFLICT AT THE BOARD LEVEL WILL NORMALLY RESULT IN RECUSAL OF THE INDIVIDUAL FROM PARTICIPATION OR ACTIVITIES WITH RESPECT TO THE RELEVANT SUBJECT MATTER. AT THE STAFF LEVEL, THE APPLICABLE BIO SUPERVISOR IS INFORMED OF THE POTENTIAL CONFLICT AND IS REQUIRED TO TAKE ALL APPROPRIATE STEPS TO ENSURE THAT THE INDIVIDUAL DOES NOT PARTICIPATE IN, OR RECEIVE CONFIDENTIAL INFORMATION RELATING TO, ANY BIO ACTIVITY RELATED TO THE SUBJECT MATTER OF THE CONFLICT, UP TO AND INCLUDING, WHERE APPROPRIATE, TERMINATION OF SUCH EMPLOYEE. FORM 990, PART VI, SECTION B, LINE 15 FOR 2016, THE PRESIDENT AND CHIEF EXECUTIVE OFFICER (CEO) OF BIO WAS COMPENSATED PER THE TERMS OF A MULTI-YEAR CONTRACT THAT WAS DETERMINED WITH INDEPENDENT REVIEW, COMPARABILITY DATA, AND CONTEMPORANEOUS SUBSTANTIATION OF THE DELIBERATION AND DECISION AS INDICATED IN PRIOR FORM 990 SUBMISSIONS. IN ADDITION, BASED ON THE EXECUTIVE COMMITTEE'S EVALUATION OF THE PRESIDENT AND CEO'S PERFORMANCE FOR 2016, THE COMMITTEE DETERMINED THE APPROPRIATE AMOUNT FOR THE DISCRETIONARY COMPONENT OF HIS COMPENSATION FOR THAT YEAR, IN ACCORDANCE WITH PROVISION OF THE EXECUTIVE AGREEMENT. DECISIONS REGARDING THE COMPENSATION FOR OFFICERS AND KEY EMPLOYEES OF THE ORGANIZATION ARE NEGOTIATED INDIVIDUALLY AND ARE PERFORMANCE-BASED, IN ACCORDANCE WITH AN ANNUAL WRITTEN EVALUATION PROCESS THAT HAS BEEN ESTABLISHED FOR ALL EMPLOYEES OF THE ORGANIZATION. THE CHIEF OPERATING OFFICER AND THE ACTING CHIEF OPERATING OFFICER LED THE PROCESS, IN COORDINATION WITH THE PRESIDENT & CEO. AN INDEPENDENT CONSULTANT PROVIDES COMPARATIVE BENCHMARKING SERVICES FOR SENIOR MANAGEMENT POSITIONS, AND OTHER INFORMATION ON COMPENSATION ISSUES, TRENDS, POLICIES, AND BEST PRACTICES FOR USE BY THE ORGANIZATION. THE ORGANIZATION ALSO HAS AN ESTABLISHED COMPENSATION POLICY FOR ALL OF ITS EMPLOYEES, WHICH SETS FORTH THE GENERAL PARAMETERS GOVERNING BIO'S COMPENSATION PRACTICES. FORM 990, PART VI, SECTION C, LINE 19 THE ORGANIZATION DOES NOT MAKE ITS GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY, AND FINANCIAL STATEMENTS AVAILABLE TO THE PUBLIC. FORM 990, PART IX, LINE 11G EC EMERGING PRIORITIES 8,709,179. CONSULTANTS AND OTHER PROFESSIONAL FEES 2,371,728. WORKPLAN OBJECTIVES 358,994. ECONOMIC STUDIES 252,345. RECRUITMENT 179,801. TEMPORARY HELP 141,470. PROGRAM INITIATIVES 84,770. BUSINESS STRATEGIES 78,312. EDUCATION 62,036. INTERNS 34,755. BIO-PAC ADMINISTRATIVE 28,948. I&E INITIATIVES 13,592. I&E FOCUS GROUPS 5,000. CEO DELEGATION EXPENSE 3,890.